Inactive Instrument
Quotes Provectus Biopharmaceuticals Inc NYSE
Stocks
US74373P1084
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 06-18 | Provectus Biopharmaceuticals, Inc. - Shareholder/Analyst Call | |
| 05-18 | Provectus Biopharmaceuticals reports oral pv-10 anti-tumor activity in preclinical bladder cancer study | RE |
Basic data
Market Cap (USD)
28,747,143
Net sales ()
0
Free-Float
92.21 %
Free-Float capitalization (USD)
26,506,626
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 28.75M | |
| -7.92% | -4.05% | +53.28% | +106.11% | 57.55B | |
| +8.55% | +17.52% | +72.65% | +82.31% | 47.08B | |
| -0.45% | -2.18% | -14.16% | -15.80% | 22.92B | |
| +1.28% | +5.09% | -2.30% | +418.34% | 22.14B | |
| +4.93% | +10.45% | +32.45% | -11.47% | 16.33B | |
| -0.15% | +4.15% | +27.79% | -34.84% | 15.97B | |
| +2.98% | +0.82% | +15.64% | +166.21% | 12.9B | |
| +5.94% | +14.85% | +134.05% | +296.09% | 12.85B | |
| -0.71% | +1.98% | +78.88% | +114.48% | 11.84B | |
| Average | +1.61% | +5.67% | +44.25% | +124.60% | 21.96B | |
| Weighted average by Cap. | +0.68% | +5.35% | +45.28% | +115.87% |
Historical Quotes: Provectus Biopharmaceuticals Inc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- PVCT Stock
- Stock
- Quotes Provectus Biopharmaceuticals Inc
Select your edition
All financial news and data tailored to specific country editions
